🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety of a daily single oral ...
Status
Completed
Location
Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna
Start Date
2009-11
Trial ID
NCT01632605
Treatments Being Tested
CMN-001 is an autologous, tumor antigen-loaded dendritic cell immunotherapy...
Status
Terminated
Location
Moffitt Cancer Center
Start Date
2020-07-22
Trial ID
NCT04203901
Treatments Being Tested
This study was designed to compare 3 immunosuppression regimens: sirolimus ...
Status
Completed
Location
Hospital do Rim
Start Date
2017-06-18
Trial ID
NCT03468478
Treatments Being Tested
Cancer drugs which target the effects of abnormal gene changes are called '...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2018-03-23
Trial ID
NCT03297606
RATIONALE: Drugs used in chemotherapy, such as sirolimus, work in different...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-08
Trial ID
NCT00311623
Treatments Being Tested
Background: The drug pemetrexed is used to treat non-small cell lung cance...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-02-29
Trial ID
NCT00923273
Treatments Being Tested
This is a pediatric kidney transplant study comparing the safety and effica...
Status
Recruiting
Location
University of Alabama at Birmingham (Site # 71038)
Start Date
2024-05-22
Trial ID
NCT06055608
This is a small phase I study with dose escalation and dose expansion cohor...
Status
Unknown
Location
Clinical Research Center
Start Date
2018-02-22
Trial ID
NCT03217669
Treatments Being Tested
The purpose of this study is to determine the feasibility of giving (i) rap...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2011-06
Trial ID
NCT01396200
Treatments Being Tested